Geneos Wealth Management’s PureCycle Technologies PCT Stock Holding History

Geneos Wealth Management’s Portfolio PCT Stock Details PCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.8K	Buy	1,700 +700	+70%	+$6.28K	﹤0.01%	1917
2026 Q1	$5.19K	Buy	1,000 +500	+100%	+$4.16K	﹤0.01%	2154
2025 Q4	$4.29K	Hold	500	–	–	﹤0.01%	2184
2025 Q3	$6.58K	Hold	500	–	–	﹤0.01%	2081
2025 Q2	$6.85K	Hold	500	–	–	﹤0.01%	2467
2025 Q1	$3.46K	Hold	500	–	–	﹤0.01%	2625
2024 Q4	$5.13K	Hold	500	–	–	﹤0.01%	2326
2024 Q3	$4.75K	Hold	500	–	–	﹤0.01%	2084
2024 Q2	$2.96K	Hold	500	–	–	﹤0.01%	1812
2024 Q1	$3.11K	Hold	500	–	–	﹤0.01%	1802
2023 Q4	$2.02K	Hold	500	–	–	﹤0.01%	1917
2023 Q3	$2.81K	Buy	+500	New	+$4.69K	﹤0.01%	1872

Other funds holding PCT

Sylebra Capital Palo Alto, California $945M AUM 22.34% 1-Year Est. Return

AWC

Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LAMI

Longview Asset Management (Illinois) Chicago, Illinois $9.89B AUM 19.81% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $26.8B AUM 90.85% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Geneos Wealth Management's PCT Position: Q2 2026 in Review

Geneos Wealth Management increased its PureCycle Technologies (PCT) stake by 70% in Q2 2026, buying an estimated $6.28K and bringing the position to 1,700 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

Geneos Wealth Management first reported a position in PCT in Q3 2023 and has held it in 12 quarters since. 312 funds tracked by Wall St. Rank hold PCT as of Q2 2026.

Geneos Wealth Management held 1,700 shares of PureCycle Technologies worth $13.8K as of Q2 2026.
Geneos Wealth Management bought 700 PureCycle Technologies shares in Q2 2026, an estimated $6.28K.
PureCycle Technologies made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1917 holding.
Geneos Wealth Management first reported a position in PureCycle Technologies in Q3 2023 and has held it in 12 quarters since.
312 funds tracked by Wall St. Rank held PureCycle Technologies as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.